U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07475936) titled 'Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke' on March 13.
Brief Summary: The benefit of intravenous tenecteplase in very old patients with acute ischemic stroke (AIS) remain uncertain. This real-world study aims to evaluate the effectiveness and safety of intravenous tenecteplase in AIS patients aged 80 years or older within 4.5 hours of symptom onset.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Acute Ischemic Stroke
Tenecteplase
Intervention:
DRUG: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Tenecteplase is administered as a single intravenous bolus at a dose of 0....